Day 1

12:00 WELCOME

12:10 Renal histology in ANCA-associated vasculitis- Ingeborg Bajema
12:40 Pulmonary lesions in PR3-and MPO-ANCA vasculitis- Ulrich Specks
13:10 Beyond B-cell depletion in ANCA-associated vasculitis – new strategies ahead? – Benjamin Terrier 

13:40 COFFEE BREAK

14:00 Drug-induced vasculitis – focus on anti-tumour agents- Augusto Vaglio  
14:30 IgG4-related disease: the true “chameleon” in medicine- John Stone

15:00 COFFEE BREAK

15:30 Diagnosis of monoclonal gammopathy of renal significance / multiple myeloma- Mariam Priya Alexander
16:00 Management of MGRS in the year 2022- Ladan Zand
16:30 Inflammatory pathways in multiple myeloma: complement and beyond- Luis Quintana 
17:00 MM and AL-Amyloidosis – treatment in patients with compromised renal function. Choice and sequencing of drugs in 2022- Stathis Kastritis

17:30 Come together & CONSENSUS PAPER Meeting

19:00 Conference DINNER

Day 2

09:00 Donors with history of malignancy- Hatem Amer 
09:30 Post-tranplant lymphoproliferative disorder (PTLD): Evidence-based treatment- Daan Dierickx 
10:00 Cancer risk in the CKD/transplant population- Hatem Amer 

10:30 COFFEE

11:00 Pathomechanisms leading to hypercoagulability- Henri Versteeg
11:30 Cancer-associated thrombosis and management- Nick Van Es 
12:00 Thrombosis in the context of nephrotic syndrome- Jack Wetzels
12:30 Thrombotic microangiopathy: why do we need a multi-disciplinary management and how long shall we treat?- Meera Sridharan 

13:00 LUNCH

14:00 Membranous nephropathy- Fernando Fervenza 
14:30 Malignancy/tumour-associated nephrotic syndrome- Ladan Zand 
15:00 Risk prediction model for AKI prior to initiation of cancer treatment – Laura Cosmai

15:30 COFFEE BREAK

16:00 Toxicity in the aera of CART cells- David Miklos 
16:30 Nephrotoxicity of new cancer immunotherapies- Sandra Herrmann

17:00 Closing Remarks & END of the Meeting

Program for download: http://iwww.congressinfo.net/files/283_programm.pdf